<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04830488</url>
  </required_header>
  <id_info>
    <org_study_id>VICC HN 2123</org_study_id>
    <nct_id>NCT04830488</nct_id>
  </id_info>
  <brief_title>Body Image After Head and Neck Cancer Treatment</brief_title>
  <acronym>BIHNC</acronym>
  <official_title>Pilot Testing of the Body Image After Head and Neck Cancer Treatment (BIHNC) Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bethany Rhoten</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt-Ingram Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study of the Body Image after Head and Neck Cancer Treatment Program [BIHNC].&#xD;
      It is a six-week, psychoeducational, web-based program that includes e-learning didactic&#xD;
      modules and personal reflection activities for participants to complete.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Aim 1: To assess the feasibility and acceptability of [BIHNC] in patients who have&#xD;
      completed treatment for head and neck cancer and who have body image concerns.&#xD;
&#xD;
      H1a: Eighty percent of enrolled study participants who complete baseline self-report measures&#xD;
      will complete the BIHNC Program.&#xD;
&#xD;
      H1b: Eighty percent of study participants completing the BIHNC Program will rate it&#xD;
      acceptable on the intervention evaluation form.&#xD;
&#xD;
      Specific Aim 2: To assess the preliminary efficacy of BIHNC for reducing body image concerns&#xD;
      in patients who have completed treatment for head and neck cancer and who have body image&#xD;
      concerns.&#xD;
&#xD;
      H2: Body image scores will improve from pre- to post- intervention&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of participants who complete program</measure>
    <time_frame>Approximately 6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of participants who will rate program as acceptable</measure>
    <time_frame>Approximately 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with improvement in body image indicators</measure>
    <time_frame>Approximately 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Head and Neck Cancer</condition>
  <arm_group>
    <arm_group_label>Body Image after Head and Neck Cancer Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>e-learning didactic module</intervention_name>
    <description>Participants utilize e-learning</description>
    <arm_group_label>Body Image after Head and Neck Cancer Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Personal reflection activities</intervention_name>
    <description>Participants complete questionnaires</description>
    <arm_group_label>Body Image after Head and Neck Cancer Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Completion of any form of head and neck cancer treatment between 3 and 9 months&#xD;
             previously at study enrollment&#xD;
&#xD;
          -  Answer in the affirmative to at least one of two questions concerning dissatisfaction&#xD;
             with the way their body looks or function&#xD;
&#xD;
          -  Have clinically significant body image concerns as defined by (BIS score &gt; 10)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Undergoing head and neck cancer treatment at time of study enrollment&#xD;
&#xD;
          -  Cognitive impairment that would preclude ability to provide informed consent&#xD;
&#xD;
          -  Unable to read text on a computer screen&#xD;
&#xD;
          -  Not able to read and understand English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bethany Rhoten, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bethany Rhoten, PhD</last_name>
    <phone>800-811-8480</phone>
    <email>bethany.rhoten@vanderbilt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vanderbilt-Ingram Service Information Program</last_name>
    <phone>800-811-8480</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bethany Rhoten, PhD</last_name>
      <email>bethany.rhoten@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Vanderbilt-Ingram Service Information Program</last_name>
      <phone>800-811-8480</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt-Ingram Cancer Center</investigator_affiliation>
    <investigator_full_name>Bethany Rhoten</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>body image</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

